ArticleLife science alliance2021

High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.

María Luisa Rodríguez de la Concepción et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.